BeOne Medicines: Redefining Cancer Care
11:53
BeOne Medicines: Redefining Cancer Care
1.6K views9 months ago
YouTubeMorgan Stanley
We Are BeOne Medicines
1:28
We Are BeOne Medicines
11.6K viewsMay 27, 2025
YouTubeBeOne Medicines
Episode 13: Inside BeOne’s Global Oncology Pipeline with Dr. Mark Lanasa
21:04
Episode 13: Inside BeOne’s Global Oncology Pipeline with Dr. Mark Lanasa
48.3K views9 months ago
YouTubeBeOne Medicines
Episode 3: The History of Co-Founder, Chairman, and CEO John V. Oyler
29:38
Episode 3: The History of Co-Founder, Chairman, and CEO John V. Oyler
302.8K viewsJul 15, 2025
YouTubeBeOne Medicines
🎉 Celebrating 1 Year of Innovation at Hopewell! Since opening in 2024, our flagship U.S. biologics manufacturing and clinical R&D facility has become a cornerstone of BeOne’s global network—accelerating cancer innovation, advancing our pipeline, and expanding access for patients worldwide. Learn more about our progress and how Hopewell is helping us reach more patients, faster. | BeOne Medicines
1:01
🎉 Celebrating 1 Year of Innovation at Hopewell! Since opening in 2024, our flagship U.S. biologics manufacturing and clinical R&D facility has become a cornerstone of BeOne’s global network—accelerating cancer innovation, advancing our pipeline, and expanding access for patients worldwide. Learn more about our progress and how Hopewell is helping us reach more patients, faster. | BeOne Medicines
52.9K viewsJul 23, 2025
FacebookBeOne Medicines
We’re proud to announce our new name—BeOne Medicines—and our redomiciliation to Switzerland are now officially in effect. This marks a major milestone in our evolution as a company. BeOne is more than just a name change. It reflects who we are today as a leading global oncology company—and our bold ambition to redefine the future of cancer care. With a powerful oncology portfolio, a pioneering approach to clinical development, and expanded global manufacturing and commercial capabilities, we’re
1:28
We’re proud to announce our new name—BeOne Medicines—and our redomiciliation to Switzerland are now officially in effect. This marks a major milestone in our evolution as a company. BeOne is more than just a name change. It reflects who we are today as a leading global oncology company—and our bold ambition to redefine the future of cancer care. With a powerful oncology portfolio, a pioneering approach to clinical development, and expanded global manufacturing and commercial capabilities, we’re
72.7K viewsMay 27, 2025
FacebookBeOne Medicines
Our team globally is aligned to one mission: to develop impactful medicines that are accessible to cancer patients around the world. 🌍 Meet Sameer, Manager in the Drug Product Department and a valued member of our team who works at our manufacturing and clinical R&D facility in Hopewell, N.J. Learn more about how his personal experience with cancer motivates him in his work every day. 💙 Explore careers here: https://ow.ly/ppta50VAYtE #Oncology #PatientsFirst #BeOneTeam | BeOne Medicines
0:51
Our team globally is aligned to one mission: to develop impactful medicines that are accessible to cancer patients around the world. 🌍 Meet Sameer, Manager in the Drug Product Department and a valued member of our team who works at our manufacturing and clinical R&D facility in Hopewell, N.J. Learn more about how his personal experience with cancer motivates him in his work every day. 💙 Explore careers here: https://ow.ly/ppta50VAYtE #Oncology #PatientsFirst #BeOneTeam | BeOne Medicines
11K viewsApr 15, 2025
FacebookBeOne Medicines
1:03
"What we work on is bigger than who we are." At BeiGene, we believe every role is part of a mission to deliver life-changing medicines to those who need them most. Meet Olivia, a valued member of our manufacturing team, as she shares how her work brings both pride and purpose. 💙 Watch her story and see how we’re making a difference, together. Interested in learning more about working at BeiGene? Visit https://ow.ly/sANB50UY3q2. #Oncology #PatientsFirst | BeOne Medicines
6.6K viewsFeb 13, 2025
FacebookBeOne Medicines
0:53
As the treatment landscape for CLL evolves, long-term data play a critical role in helping clinicians understand the clinical profile of treatments over time. As we reach the final stretch of #ASH25, we connected with Dany Habr, Head of Medical Affairs, to discuss new long-term data shared today and why it matters for patients with CLL. Don’t miss his final update and be sure to explore more on our congress site: https://congress.beonemedicines.com/?utm_campaign=beone_01_pan_ub_corpaff_all_us_fy
43K views10 months ago
FacebookBeOne Medicines
0:05
We’re excited to announce the U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. | BeOne Medicines
430 viewsMar 17, 2025
FacebookBeOne Medicines
See more
Static thumbnail place holder